July 26, 2019 / 5:09 AM / 3 months ago

BRIEF-Idorsia Says Janssen Reports Positive Top-Line Phase 3 Results For Ponesimod

July 26 (Reuters) - IDORSIA LTD:

* JANSSEN REPORTS POSITIVE TOP-LINE PHASE 3 RESULTS FOR PONESIMOD IN ADULTS WITH RELAPSING MULTIPLE SCLEROSIS

* JANSSEN REPORTS POSITIVE TOP-LINE PHASE 3 RESULTS FOR PONESIMOD IN ADULTS WITH RELAPSING MULTIPLE SCLEROSIS

* IDORSIA PHARMACEUTICALS LTD IS ENTITLED TO RECEIVE QUARTERLY PAYMENTS OF 8% OF NET SALES OF PONESIMOD PRODUCTS FROM ACTELION PHARMACEUTICALS LTD

* STUDY MET ITS PRIMARY AND MOST SECONDARY ENDPOINTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below